Free Trial
NASDAQ:ALEC

Alector (ALEC) Stock Price, News & Analysis

Alector logo
$2.35 -0.04 (-1.67%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$2.35 0.00 (-0.21%)
As of 08/29/2025 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Alector Stock (NASDAQ:ALEC)

Key Stats

Today's Range
$2.31
$2.44
50-Day Range
$1.38
$2.52
52-Week Range
$0.87
$6.37
Volume
465,077 shs
Average Volume
1.62 million shs
Market Capitalization
$237.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.17
Consensus Rating
Hold

Company Overview

Alector Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
79th Percentile Overall Score

ALEC MarketRank™: 

Alector scored higher than 79% of companies evaluated by MarketBeat, and ranked 217th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Alector has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on 4 buy ratings, 1 hold rating, and 2 sell ratings.

  • Amount of Analyst Coverage

    Alector has only been the subject of 1 research reports in the past 90 days.

  • Read more about Alector's stock forecast and price target.
  • Earnings Growth

    Earnings for Alector are expected to decrease in the coming year, from ($1.88) to ($1.98) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Alector is -2.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Alector is -2.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Alector has a P/B Ratio of 3.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Alector's valuation and earnings.
  • Percentage of Shares Shorted

    7.47% of the float of Alector has been sold short.
  • Short Interest Ratio / Days to Cover

    Alector has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in Alector has recently decreased by 3.24%, indicating that investor sentiment is improving.
  • Dividend Yield

    Alector does not currently pay a dividend.

  • Dividend Growth

    Alector does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.47% of the float of Alector has been sold short.
  • Short Interest Ratio / Days to Cover

    Alector has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in Alector has recently decreased by 3.24%, indicating that investor sentiment is improving.
  • News Sentiment

    Alector has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.05 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Alector this week, compared to 2 articles on an average week.
  • Search Interest

    6 people have searched for ALEC on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Alector to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Alector insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $34,480.00 in company stock.

  • Percentage Held by Insiders

    Only 9.70% of the stock of Alector is held by insiders.

  • Percentage Held by Institutions

    85.83% of the stock of Alector is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Alector's insider trading history.
Receive ALEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alector and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ALEC Stock News Headlines

Alector (NASDAQ:ALEC) Director Paula Hammond Sells 14,000 Shares
Alector to Participate in Upcoming Healthcare Conferences
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.tc pixel
Alector Inc. (ALEC) Stock Price Today - WSJ
3 Promising Penny Stocks With Market Caps Above $200M
Alector, Inc. (ALEC) Q2 2025 Earnings Call Transcript
See More Headlines

ALEC Stock Analysis - Frequently Asked Questions

Alector's stock was trading at $1.89 at the beginning of 2025. Since then, ALEC shares have increased by 24.3% and is now trading at $2.35.

Alector, Inc. (NASDAQ:ALEC) released its quarterly earnings results on Thursday, August, 7th. The company reported ($0.30) earnings per share for the quarter, beating the consensus estimate of ($0.45) by $0.15. The firm earned $7.87 million during the quarter, compared to analysts' expectations of $2.76 million. Alector had a negative net margin of 142.10% and a negative trailing twelve-month return on equity of 112.06%.
Read the conference call transcript
.

Alector subsidiaries include these companies: Alector LLC.

Alector (ALEC) raised $177 million in an IPO on Thursday, February 7th 2019. The company issued 9,300,000 shares at a price of $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays served as the underwriters for the IPO.

Alector's top institutional investors include Acadian Asset Management LLC (2.17%), Geode Capital Management LLC (1.98%), Sio Capital Management LLC (0.84%) and TD Asset Management Inc (0.65%). Insiders that own company stock include Polaris Venture Management Co, Arnon Rosenthal, Sara Kenkare-Mitra, Marc Grasso, Gary Romano, Kristine Yaffe and Paula Hammond.
View institutional ownership trends
.

Shares of ALEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alector investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Enovix (ENVX), Meta Platforms (META), Rambus (RMBS), Saia (SAIA) and Tesla (TSLA).

Company Calendar

Last Earnings
8/07/2025
Today
8/30/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ALEC
CIK
1653087
Fax
N/A
Employees
270
Year Founded
2013

Price Target and Rating

High Price Target
$10.00
Low Price Target
$1.00
Potential Upside/Downside
+77.3%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$119.05 million
Net Margins
-142.10%
Pretax Margin
-142.04%
Return on Equity
-112.06%
Return on Assets
-26.37%

Debt

Debt-to-Equity Ratio
0.13
Current Ratio
3.78
Quick Ratio
3.78

Sales & Book Value

Annual Sales
$100.56 million
Price / Sales
2.37
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.70 per share
Price / Book
3.36

Miscellaneous

Outstanding Shares
101,210,000
Free Float
91,394,000
Market Cap
$237.84 million
Optionable
Optionable
Beta
0.86

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:ALEC) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners